HMCIB SPAC 3
Bonne Co., Ltd. develops and supplies cosmetics in South Korea. The company offers skin care products, including whitening, wrinkle and pimple treatment, stem-cell peptide, and nano peptide products; and sun care products comprising fluids, creams, emulsions, etc. It also provides hair and body care products; makeup products, such as foundation, powder, compact, loose powder, BB cream, eye liner,… Read more
HMCIB SPAC 3 (226340) - Total Liabilities
Latest total liabilities as of September 2024: ₩29.73 Billion KRW
Based on the latest financial reports, HMCIB SPAC 3 (226340) has total liabilities worth ₩29.73 Billion KRW as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
HMCIB SPAC 3 - Total Liabilities Trend (2015–2023)
This chart illustrates how HMCIB SPAC 3's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
HMCIB SPAC 3 Competitors by Total Liabilities
The table below lists competitors of HMCIB SPAC 3 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zhejiang Yuancheng Landscape
SHG:603388
|
China | CN¥1.44 Billion |
|
Tong Ming Enterprise Co Ltd
TW:5538
|
Taiwan | NT$6.51 Billion |
|
Axita Cotton Limited
NSE:AXITA
|
India | ₹329.43 Million |
|
Redtone International Bhd
KLSE:0032
|
Malaysia | RM135.88 Million |
|
PT Duta Pertiwi Tbk
F:DUI
|
Germany | €2.46 Trillion |
|
Inalways
TWO:5398
|
Taiwan | NT$93.01 Million |
Liability Composition Analysis (2015–2023)
This chart breaks down HMCIB SPAC 3's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.71 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.54 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.33 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how HMCIB SPAC 3's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for HMCIB SPAC 3 (2015–2023)
The table below shows the annual total liabilities of HMCIB SPAC 3 from 2015 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | ₩47.65 Billion | -19.20% |
| 2022-12-31 | ₩58.97 Billion | -3.55% |
| 2021-12-31 | ₩61.14 Billion | +178.69% |
| 2020-12-31 | ₩21.94 Billion | +208.43% |
| 2019-12-31 | ₩7.11 Billion | -25.38% |
| 2018-12-31 | ₩9.53 Billion | +891.73% |
| 2017-12-31 | ₩961.20 Million | +3.41% |
| 2016-12-31 | ₩929.50 Million | +3.73% |
| 2015-12-31 | ₩896.04 Million | -- |